Stockreport

Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program

IPSEN SA S/ADR  (IPSEY) 
NASDAQ:AMEX Investor Relations: ipsen.com/investors
PDF - Ipsen obtains exclusive option to global license a research program for a selective disease-modifying approach to neurodegenerative diseases SAN DIEGO--(BUSINESS WI [Read more]